Global Gene Therapy Cell Culture Media Market (2020 to 2027) - Opportunity Analysis and Industry Forecasts
April 08, 2021 06:18 ET
|
Research and Markets
Dublin, April 08, 2021 (GLOBE NEWSWIRE) -- The "Gene Therapy Cell Culture Media Market by Media Type, Viral Vectors Type and End User: Global Opportunity Analysis and Industry Forecast, 2020-2027"...
Worldwide Sterile Filtration Industry to 2026 - Key Drivers, Restraints and Opportunities
March 15, 2021 08:38 ET
|
Research and Markets
Dublin, March 15, 2021 (GLOBE NEWSWIRE) -- The "Sterile Filtration Market by Type, Membrane Type, Application, End-User, and Geography - Global Forecast to 2026" report has been added to...
$5.6 Billion Cell Therapy Technologies Markets, 2025 with Thermo Fisher Scientific, Merck KGaA, and Danaher Dominating
February 01, 2021 08:33 ET
|
Research and Markets
Dublin, Feb. 01, 2021 (GLOBE NEWSWIRE) -- The "Cell Therapy Technologies Market Report - Global Forecast to 2025" report has been added to ResearchAndMarkets.com's offering. The Global Cell Therapy...
Increasing Investment in the R&D of Life Sciences Going to Boost the Global Culture Media Market in Upcoming Years – Exclusive Report [230 Pages] by Research Dive
October 28, 2020 09:00 ET
|
Research Dive
New York, USA, Oct. 28, 2020 (GLOBE NEWSWIRE) -- The global culture media market forecast will surpass $5,398.6 million by 2027, at a CAGR of 7.7%, increasing from $2,975.6 million in 2019,...
Precipio & ADS Biotec Launch Seven Beta sites for IV-Cell™
October 06, 2020 10:00 ET
|
Precipio, Inc.
NEW HAVEN, Conn., Oct. 06, 2020 (GLOBE NEWSWIRE) -- Specialty cancer diagnostics company Precipio, Inc. (NASDAQ: PRPO), along with its partner ADS Biotec announce the launch of the beta phase...
Global Sterile Filtration Market by Product, Application, Membrane, Pore Size, End User and Region - Forecast to 2025
August 31, 2020 07:54 ET
|
Research and Markets
Dublin, Aug. 31, 2020 (GLOBE NEWSWIRE) -- The "Sterile Filtration Market by Product (Cartridge, Capsule, Syringe), Application (Fill Finish Process, Bioburden Reduction), Membrane (Nylon, PTFE, PES,...
Precipio Conducts IV-Cell™ Validation Trial with a Prominent Laboratory
May 06, 2019 09:20 ET
|
Precipio, Inc.
NEW HAVEN, Conn., May 06, 2019 (GLOBE NEWSWIRE) -- Specialty diagnostics company Precipio, Inc. (NASDAQ: PRPO), announced that it is in the process of completing a trial of its Proprietary IV-Cell...
Precipio Identifies Manufacturer for its IV-Cell Media
April 09, 2019 09:15 ET
|
Precipio, Inc.
NEW HAVEN, Conn., April 09, 2019 (GLOBE NEWSWIRE) -- Specialty diagnostics company Precipio, Inc. (NASDAQ: PRPO) announced today that it is negotiating a definitive agreement with a manufacturer to...
Precipio in Strategic Partnership Discussions for Proprietary Cytogenetics Media IV-Cell
April 18, 2018 07:38 ET
|
Precipio, Inc.
NEW HAVEN, Conn., April 18, 2018 (GLOBE NEWSWIRE) -- Specialty diagnostics company Precipio, Inc. (NASDAQ:PRPO), announced today it is in active licensing discussions with several potential partners...